Status:
COMPLETED
Extracorporeal Blood Purification as a Treatment Modality for COVID-19
Lead Sponsor:
Zan Mitrev Clinic
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have suggested a potential clinical benefit of controlling hyper inflammation triggered by SARS-CoV-2/COVID-19. Blood purification, the removal of excessive proinflammatory mediators m...
Detailed Description
COVID-19 disease progression is associated with dysregulated immunity, commonly referred to as cytokine storm, in particular, aberrant Interleukin (IL) 6 levels that promote numerous pathological down...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 disease:
- RT-PCR
- Atypical Pneumonia; X-Ray and/or Computed Tomography
- ≥ 1 oXiris® blood purification cycle
Exclusion
- Pregnancy
- Heart failure; severe systolic dysfunction, left ventricular ejection fraction \< 25% requiring urgent surgery
- Aortic Aneurysms, dissection or rupture requiring urgent surgery
- Recent Myocardial Infarction; cardiovascular disease patients requiring urgent surgery
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04478539
Start Date
June 1 2020
End Date
July 1 2021
Last Update
December 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zan Mitrev Clinic
Skopje, North Macedonia, 1000